Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that its abstract detailing clinical results ongoing Phase 1/2 trial ...

Leerink Partners Global Healthcare Conference Format: Fireside Chat Date: Wednesday, March 11, 2026 Time: 8:00 AM ET Webcast ...

India leads the world in hand transplants, performing 73 by late 2024. Experts credit skilled microsurgeons and coordination but cite low donor rates and complex rehab as ongoing challenges.

When a donor organ is given to a recipient, it’s crucial that the recipient's immune system does not attack the donated organ as an invader... | Cell And Molecular Biology ...

Immunocompromised status remains a significant risk factor for in-hospital mortality in COVID-19, particularly among patients with pneumonia.

Recent transactions make clear that large pharmaceutical companies now view rare disease as a core area for sustained growth, rather than episodic deal-making. BioMarin’s acquisition of Amicus ...

By Hugo Francisco de Souza New research suggests that zinc does far more than support immunity, revealing intricate molecular switches that may influence how the heart responds to inflammatory injury.

While the combination of pembrolizumab with standard-of-care (SOC) radiation, and androgen deprivation therapy (ADT) with or ...

A GREENOCK woman who brushed off a sore throat as a bout of the flu before setting off on holiday ended up in a coma fighting for life. Jennifer Gavin thought she had come down with a 'generic bug' ...